Your browser doesn't support javascript.
loading
Commentary: Should Pharmacogenomic Evidence Be Considered in Clinical Decision Making? Focus on Select Cardiovascular Drugs.
Bottorff, Michael B; Bright, David R; Kisor, David F.
Afiliación
  • Bottorff MB; Department of Pharmacy Practice, College of Pharmacy, Natural and Health Sciences, Manchester University, Fort Wayne, Indiana.
  • Bright DR; Department of Pharmaceutical Sciences, College of Pharmacy, Ferris State University, Grand Rapids, Michigan.
  • Kisor DF; Department of Pharmaceutical Sciences, College of Pharmacy, Natural and Health Sciences, Manchester University, Fort Wayne, Indiana.
Pharmacotherapy ; 37(9): 1005-1013, 2017 Sep.
Article en En | MEDLINE | ID: mdl-28654154
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Farmacogenética / Fármacos Cardiovasculares / Medicina Basada en la Evidencia / Toma de Decisiones Clínicas Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Pharmacotherapy Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Farmacogenética / Fármacos Cardiovasculares / Medicina Basada en la Evidencia / Toma de Decisiones Clínicas Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Pharmacotherapy Año: 2017 Tipo del documento: Article